Skip to main content

Advertisement

SpringerLink
Log in

Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objectives

Patients with psoriasis may have a higher risk of developing chronic kidney (CKD) and end-stage renal disease (ESRD) compared with general population. This systematic review and meta-analysis aimed to comprehensively investigate this association by reviewing all available evidence.

Methods

A systematic review was performed using MEDLINE and EMBASE database from inception to January 2018 to identify all cohort studies that compared the risk of incident CKD and/or ESRD in patients with psoriasis versus individuals without psoriasis. Pooled risk ratio and 95% confidence interval were calculated using random-effect, generic inverse variance method.

Results

A total of four retrospective cohort studies with 199,808 patients with psoriasis were included. The risk of incident CKD and ESRD was significantly increased among patients with psoriasis with the pooled risk ratio of 1.34 (95% CI, 1.14–1.57) and 1.29 (95% CI, 1.05–1.60), respectively.

Conclusion

A significantly increased risk of incident CKD and ESRD among patients with psoriasis compared with individuals without psoriasis was demonstrated in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Naldi L (2004) Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 3:121–128

    Article  PubMed  CAS  Google Scholar 

  2. Gisondi P (2017) High prevalence of alcohol use disorders in patients with inflammatory skin diseases applies to both psoriasis and eczema. Br J Dermatol 177:606–607

    Article  PubMed  CAS  Google Scholar 

  3. Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29:428–434

    Article  PubMed  CAS  Google Scholar 

  4. Correia B, Torres T (2015) Obesity: a key component of psoriasis. Acta Biomed 86:121–129

    PubMed  CAS  Google Scholar 

  5. Naldi L, Mercuri SR (2009) Smoking and psoriasis: from epidemiology to pathomechanism. J Invest Dermatol 129:2741–2743

    Article  PubMed  CAS  Google Scholar 

  6. Kokpol C, Aekplakorn W, Rajatanavin N (2014) Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study. J Dermatol 41:898–902

    Article  PubMed  CAS  Google Scholar 

  7. Ungprasert P, Sanguankeo A, Upala S et al (2014) Psoriasis and venous thromboembolism: a systematic review and meta-analysis. QJM 107:793–797

    Article  PubMed  CAS  Google Scholar 

  8. Ungprasert P, Srivali N, Kittanamongkolchai W (2016) Psoriasis and risk of incident atrial fibrillation: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol 82:489–497

    Article  PubMed  Google Scholar 

  9. Bissonnette R, Kerdel F, Naldi L et al (2017) Evaluation of risk of major adverse cardiovascular events with biologic therapy in patients with psoriasis. J Drugs Dermatol 16:1002–1013

    PubMed  Google Scholar 

  10. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874

    Article  PubMed  CAS  Google Scholar 

  11. Maradit-Kremers H, Nicola PJ, Crowson CS et al (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732

    Article  PubMed  Google Scholar 

  12. Wan J, Wang S, Haynes K et al (2013) Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 347:f5961

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chiu HY, Huang HL, Li CH et al (2015) Increased risk of glomerulonephritis and chronic kidney disease in relation to severity of psoriasis, concomitant medication, and comorbidity: a nation-wide population-based cohort study. Br J Dermatol 173:146–154

    Article  PubMed  Google Scholar 

  14. Parisi R, Rutter MK, Lunt M et al (2015) Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 135:2189–2197

    Article  PubMed  CAS  Google Scholar 

  15. Yu S, Tu HP, Yu CL et al (2017) Is psoriasis an independent risk factor of renal disease? A nationwide retrospective cohort study from 1996 to 2010. Dermatol Sin 35:78–84

    Article  Google Scholar 

  16. Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

    Article  PubMed  Google Scholar 

  17. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188

    Article  CAS  Google Scholar 

  18. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ozyilmaz A, de Jong PE, Gansevoort RT (2012) Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage. Nephrol Dial Transplant 27:4046–4052

    Article  PubMed  Google Scholar 

  20. Shahwan KT, Kimball AB (2015) Psoriasis and cardiovascular disease. Med Clin N Am 99:1227–1242

    Article  PubMed  Google Scholar 

  21. Ogawa E, Sato Y, Minagawa A et al (2017) Pathogenesis of psoriasis and development of treatment. J Dermatol (epub ahead of pirnt)

  22. Turner JE, Paust HJ, Steinmetz OM et al (2010) The Th17 immune response in renal inflammation. Kidney Int 77:1070e5

    Article  CAS  Google Scholar 

  23. Kitching AR, Holdsworth SR (2011) The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol 22:235e8

    Article  CAS  Google Scholar 

  24. Imai H, Kodama T, Ishino T et al (1995) IgA nephropathy associated with hyper IgAnemia, psoriasis or pustulosis and ossification. Clin Nephrol 44:64–68

    PubMed  CAS  Google Scholar 

  25. Zadrazil J, Tichy T, Horak P et al (2006) IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of ‘psoriatic nephropathy’. J Nephrol 19:382–386

    PubMed  CAS  Google Scholar 

  26. Kluger N, Du-Thanh A, Bessis D et al (2015) Psoriasis-associated IgA nephropathy under infliximab therapy. Int J Dermatol 54:e79–e80

    Article  PubMed  CAS  Google Scholar 

  27. Kaji T, Tsukada Y, Shimada A et al (1994) Membranous nephropathy associated with psoriasis vulgaris. Clin Nephrol 42:63–64

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Road, Bangkoknoi, Bangkok, 10700, Thailand

    Patompong Ungprasert

  2. Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Sukit Raksasuk

Authors
  1. Patompong Ungprasert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sukit Raksasuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors had access to the data and a role in writing the manuscript.

Corresponding author

Correspondence to Patompong Ungprasert.

Ethics declarations

Conflict of interest

We do not have any financial or non-financial potential conflicts of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 31 kb)

11255_2018_1868_MOESM2_ESM.docx

Supplementary material 2: The report of this systematic review and meta-analysis is in full compliance with the guideline meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group which is provided as supplementary data 2. (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ungprasert, P., Raksasuk, S. Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 50, 1277–1283 (2018). https://doi.org/10.1007/s11255-018-1868-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-1868-z

Keywords

Search

Navigation